Document Detail


Urinary inositol phosphoglycan P-type as a marker for prediction of preeclampsia and novel implications for the pathophysiology of this disorder.
MedLine Citation:
PMID:  20701477     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Hypertensive disorders represent the most common complications of human pregnancy with substantial impact on fetal and maternal outcomes. Inositol phosphoglycan P-type has recently been identified as a novel marker of preeclampsia, the most severe form of hypertension during pregnancy, with a significant increase in urinary excretion preceding the clinical diagnosis.
METHODS: A prospective, longitudinal study was carried out to assess the potential of urinary levels of inositol phosphoglycan P-type as a screening test for preeclampsia. A specific ELISA-based test was used to assess urinary levels of P-IPG.
RESULTS: Nine patients out of 93 women recruited (496 urinary samples were collected) went on to develop preeclampsia in a cohort of women with high-risk pregnancies. A cut-off value of urinary inositol phosphoglycan P-type was identified by ROC analysis providing a sensitivity and specificity for the current protocol of 88.9% and 62.7%, respectively. Twenty-three women with healthy pregnancies had sporadic episodes of increased excretion of inositol phosphoglycan P-type during pregnancy that consistently resolved back to normal baseline without development of preeclampsia. There was no correlation of urine levels of inositol phosphoglycan P-type and urine protein and patients with gestational hypertension had normal levels of urine inositol phosphoglycan P-type.
CONCLUSIONS: These findings suggest that, given the rapid raise of P-IPG before the onset of the disease, multiple assessments may help at identifying women at risk of developing preeclampsia.
Authors:
Malcolm A Paine; Marco Scioscia; Philip J Williams; Khalid Gumaa; Charles H Rodeck; Thomas W Rademacher
Related Documents :
580707 - Intrauterine development, feto-placental function and pregnancy outcome after induction...
18634207 - Refinement of a commercial bench-top relaxin assay for pregnancy diagnosis using urine ...
947937 - The role of 19-hydroxy-delta4-androstene-3,17-dione in the conversion of circulating de...
6541177 - Variations in urinary levels of free 6 beta-hydroxycortisol, cortisol, and estrogens in...
17048757 - Word-of-mouth marketing: low-cost technique proves an effective way to promote teen cli...
6841417 - Iatrogenic lesions of the upper airway in the newborn.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hypertension in pregnancy : official journal of the International Society for the Study of Hypertension in Pregnancy     Volume:  29     ISSN:  1525-6065     ISO Abbreviation:  Hypertens Pregnancy     Publication Date:  2010  
Date Detail:
Created Date:  2010-09-27     Completed Date:  2011-01-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9421297     Medline TA:  Hypertens Pregnancy     Country:  England    
Other Details:
Languages:  eng     Pagination:  375-84     Citation Subset:  IM    
Affiliation:
Department of Immunology and Molecular Pathology, Molecular Medicine Unit, Royal Free and University College London Medical School, London, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analysis of Variance
Biological Markers / urine
Enzyme-Linked Immunosorbent Assay
Female
Humans
Inositol Phosphates / urine*
Polysaccharides / urine*
Pre-Eclampsia / urine*
Predictive Value of Tests
Pregnancy
Pregnancy, High-Risk / urine*
Prospective Studies
ROC Curve
Sensitivity and Specificity
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Inositol Phosphates; 0/Polysaccharides; 0/inositol phosphate glycan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Increased risk of hypertension, proteinuria and preeclampsia in pregnant Saudi females with IgA neph...
Next Document:  Skin autofluorescence as marker of tissue advanced glycation end-products accumulation in formerly p...